Sonova stock holds steady as 2026 dividend and sales targets stand out

Sonova Holding AG (ISIN CH0012549785) is holding near CHF 239.30, with MarketScreener showing a 1.27% gain and a 5-day move of 3.08% as of August 11, 2026. The latest market snapshot also shows a 14.90% rise since January 1, 2026.

Dividend and strategy

Investor attention has centered on Sonova's 2026 annual meeting, where shareholders approved all board motions and a record CHF 4.70 dividend per share. A separate company update from March 23, 2026 also set a longer-term sales target of CHF 6 billion by 2030/31 and flagged the planned sale of the Consumer Hearing business.

The combination matters because it pairs near-term cash returns with a longer runway for growth. That is the key comparison: CHF 4.70 per share in cash today against a CHF 6 billion revenue ambition by 2030/31.

Recent trading context

Sonova's stock has also held a positive year-to-date tone, with MarketScreener's quote page marking a 14.90% gain for 2026 and a CHF 239.30 reference level on August 11, 2026. The same page shows the shares were up 3.08% over five days, a useful signal for investors watching whether the move can extend.

MarketScreener also listed the company's May 18, 2026 earnings reaction alongside the note that the stock beat expectations and kept its innovation momentum intact. That keeps the focus on execution after the latest meeting and strategy updates.

Hearing-care portfolio

Sonova's core products include Phonak hearing aids, which remain central to the group's premium hearing-care franchise. That product line matters because the stock story is still tied to execution in hearing solutions rather than one-off financial engineering.

Stock setup

As of August 11, 2026, Sonova was trading at CHF 239.30 on MarketScreener's live quote page, with the company carrying a 14.90% year-to-date gain and a 5-day rise of 3.08%. That leaves the shares close enough to recent highs to keep valuation and delivery on the same page.